Tech Company Financing Transactions
Xylyx Bio Funding Round
Xylyx Bio, based in New York, received $3 million in funding from National Institutes of Health.
Transaction Overview
Company Name
Announced On
10/20/2026
Transaction Type
Debt
Amount
$2,990,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
760 Parkside Avenue
New York, NY 11226
USA
New York, NY 11226
USA
Phone
Website
Email Address
Overview
Xylyx is led by an interdisciplinary team of expert bioengineers, surgeons, physicians, and scientists with a long and prolific history of successful collaboration aimed at advancing the field of regenerative medicine.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andrea Nye
Browse more venture capital transactions:
Prev: 10/20/2026: Vrtx venture capital transaction
Next: 10/20/2026: Neolix venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs